1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,321 | 0,377 | 16:35 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SCANDINAVIAN CHEMOTECH Aktie jetzt für 0€ handeln | |||||
| 04.11. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q3 2025 | 86 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
July - September 2025 ... ► Artikel lesen | |
| 17.10. | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Surpasses 3,000 Treatments Performed Worldwide | 118 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care, a pioneer in making oncology care more compassionate and human for animals, proudly announces another achievement: over 3,000 treatments have now been performed... ► Artikel lesen | |
| 01.10. | Scandinavian ChemoTech AB: ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown | 117 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division is proud to announce another strong quarter, generating sales of USD 340,000 in Q3 2025. This result is within USD 50,000 of the company's record-breaking... ► Artikel lesen | |
| 26.09. | Scandinavian ChemoTech AB: ChemoTech's Animal Care Successfully Enters Swiss Market as Part of DACH Expansion | 462 | GlobeNewswire (Europe) | Scandinavian ChemoTech and its subsidiary VQ Animal Care Inc. is pleased to announce that it has officially started marketing vetIQure, its Tumor Specific Electroporation (TSE) technology in Switzerland.... ► Artikel lesen | |
| 19.09. | Scandinavian ChemoTech Hosts Successful TSE Best Practice Sharing Session with Dr. Brendan Boostrom | 1 | Cision News | ||
| 10.09. | Scandinavian ChemoTech AB: ChemoTech Expands in Illinois as 8th Clinic within Major U.S. Veterinary Group Adopts TSE Technology | 100 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB today announced that its veterinary subsidiary, VQ Animal Care Inc., has secured a new partnership in Illinois. With this latest order, the eighth clinic within one of the... ► Artikel lesen | |
| 25.08. | Scandinavian ChemoTech Expands in Florida with Fourth Veterinary Oncology Clinic Partnership | 2 | Cision News | ||
| 20.08. | Scandinavian ChemoTech's Animal Care Surpasses 2,500 Treatment-kits sold Worldwide | 2 | Cision News | ||
| 12.08. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q2 2025 | 145 | GlobeNewswire (Europe) | Second quarter sales reached 3,841 KSEK, which is the best quarter so far. All sales originated from Animal Care. The report is attached to this press release and can also be downloaded from the company's... ► Artikel lesen | |
| 29.07. | Scandinavian ChemoTech Welcomes Strategic Investors from the announce Directed Share Issue to Accelerate Global Growth | 2 | Cision News | ||
| 27.07. | Scandinavian ChemoTech AB (publ) carries out a directed share issue and receives approximately 4.85 MSEK | 2 | Cision News | ||
| 25.07. | (RETRANS) Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation | 1 | Cision News | ||
| 24.07. | Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation | 1 | Cision News | ||
| 01.07. | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Division Achieves Record-Breaking Sales in Q2 2025 | 158 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division proudly announces record-breaking sales in the second quarter of 2025. With continued momentum from a strong start to the quarter, the team achieved... ► Artikel lesen | |
| 06.05. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q1 2025 | 151 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) hereby publishes the Interim Report for Q1 2025.
First-quarter sales reached 2 472 KSEK, which is the best quarter so far. All sales originated from Animal Care.
First... ► Artikel lesen | |
| 04.03. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-End Report January - December 2024 | 168 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) hereby publishes the Year-End Report for 2024.
Fourth-quarter sales reached 2 041 KSEK, which is the best quarter in 2024. Total annual sales amounted to 6 566 KSEK-entirely... ► Artikel lesen | |
| 30.01. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Restructures Loans and Doubles the Duration to 12 Months | 220 | GlobeNewswire (Europe) | ChemoTech is pleased to announce the signing of new restructured loan agreements to replace its previous short-term bridge financing. The new agreements include a 2.4 MSEK loan from two external investors... ► Artikel lesen | |
| 24.01. | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care operations showed positive cashflow for 2024 in separate reporting | 254 | GlobeNewswire (Europe) | Scandinavian ChemoTech is pleased to announce that our Animal Care operations would already be showing a positive cash flow if we reported our business areas separately. This underscores the importance... ► Artikel lesen | |
| 09.01. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Implements Management Changes to Reduce Costs and Boost Revenues | 192 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB, in line with the structural changes for the group published on December 30, 2024, has decided to implement measures aimed at achieving financial sustainability. As part of... ► Artikel lesen | |
| 30.12.24 | Scandinavian ChemoTech AB: Scandinavian ChemoTech Splits Business Units to Boost Cash Flow and will suggest a new name for the group | 254 | GlobeNewswire (Europe) | Since 2021, Scandinavian ChemoTech has operated two distinct business units - Human Care and Animal Care. While Human Care was the group's initial focus, the Board of Directors has made key decisions... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,340 | +1,52 % | EQS-PVR: Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Siemens Healthineers AG
Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
01.12.2025 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,790 | -0,55 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,680 | -0,69 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius nach den Anfang November vorgelegten Zahlen zum dritten Quartal von 56 auf 57 Euro angehoben. Die Einstufung wurde... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,640 | -3,83 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,010 | -5,16 % | Procept BioRobotics stock downgraded by BofA on slowing growth | ||
| GERRESHEIMER | 25,000 | -4,80 % | INDEX-MONITOR: JPMorgan erwartet Aumovio im MDax - Dax wohl unverändert | FRANKFURT (dpa-AFX) - Im Dax dürfte zur Index-Überprüfung an diesem Mittwoch alles beim Alten bleiben. Eine Änderung erwartet die US-Bank JPMorgan dagegen im Index der mittelgroßen Unternehmen, die... ► Artikel lesen | |
| UNITEDHEALTH | 278,90 | -1,80 % | UnitedHealth: Milliarden-Deal voraus | Der unter Druck stehende größte US-Krankenversicherer UnitedHealth trennt sich wohl von einem weiteren Geschäftsbereich. Wie die Nachrichtenagentur Reuters am Wochenende berichtet, verkauft das Unternehmen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,000 | -2,21 % | IPO Stock Of The Week: Health Care Leader BrightSpring Falls Back Into Buying Range | ||
| GENEDX | 162,09 | +1,97 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| HEARTFLOW | 28,185 | +2,68 % | Heartflow, Inc.: Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform | MOUNTAIN VIEW, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it has received... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,600 | +1,17 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler und SK Biopharmaceuticals unterzeichnen Liefervertrag für Actinium-225 | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Vereinbarung/Auftragseingänge
Eckert & Ziegler und SK Biopharmaceuticals unterzeichnen Liefervertrag für Actinium-225
03.12.2025... ► Artikel lesen | |
| NUTEX HEALTH | 170,00 | +5,62 % | Nutex Health extends share repurchase plan | ||
| OTTOBOCK | 69,90 | -2,03 % | ROUNDUP/Aktien Frankfurt Schluss: Im Plus - Starke Autowerte und US-Zinshoffnung | FRANKFURT (dpa-AFX) - Der Optimismus über wohl weiter sinkende Zinsen in den USA hat am Donnerstag den deutschen Aktienmarkt angetrieben. Hinzu kam eine starke Autobranche, die dem Dax Auftrieb gab.... ► Artikel lesen | |
| MEDTRONIC | 87,64 | +0,69 % | FDA Clears Medtronic's Hugo Robotic-Assisted Surgery System For Urologic Procedures | WASHINGTON (dpa-AFX) - Medtronic (MDT) announced that it has received FDA clearance for its Hugo robotic-assisted surgery (RAS) system in urologic procedures, marking a significant milestone... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,220 | -1,69 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen |
Das Unternehmen SCANDINAVIAN CHEMOTECH AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,290 Euro und damit +1,05 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCANDINAVIAN CHEMOTECH AB finden Sie auf Wallstreet Online.